NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/24/2023
Back to search
Official data from USPTO
ARESVIQUE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/21/2023
Trademark type
Word
Nice classes
5
Filing date
11/11/2021
Registration date
01/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2023
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Rixensart, BE
Examiner
CORDOVA, RAUL
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GlaxoSmithKline Biologicals SA
Representatives
Christopher M. Hanes GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseasespaininflammationobesity and cognitive disorders; Pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalrespiratoryneurologicalgastrointestinaldermatologicalpsychiatric and immune system related diseases and disorders; (Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseasespaininflammationobesity and cognitive disorders; Pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalrespiratoryneurologicalgastrointestinaldermatologicalpsychiatric and immune system related diseases and disorders
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/05/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/30/2022
ATRV
ATTORNEY REVIEW COMPLETED
09/28/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
09/26/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/26/2022
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
08/30/2022
APET
ASSIGNED TO PETITION STAFF
08/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/20/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/15/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2022
DOCK
ASSIGNED TO EXAMINER
06/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2021
NWAP
NEW APPLICATION ENTERED
11/15/2021
Continuous trademark protection
Get notified about every new filing that threatens ARESVIQUE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.